← Back to Search

Digestive Enzyme Supplement

Zypan for Indigestion

N/A
Recruiting
Research Sponsored by National University of Natural Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4

Summary

This trial aims to investigate how a common dietary supplement impacts the quality of life and digestion in adults with functional dyspepsia.

Who is the study for?
This trial is for adults who frequently experience indigestion, specifically functional dyspepsia. The study aims to see if a dietary supplement can improve their digestion and quality of life.
What is being tested?
The trial is testing the effectiveness of Zypan, a dietary supplement, against a placebo (a pill with no active ingredients). Participants will be randomly assigned to receive either Zypan or the placebo.
What are the potential side effects?
Since the side effects are not specified here, it's important for participants to know that while Zypan is generally considered safe as it's already available on the market, any unexpected reactions should be reported.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Protein Assimilation
Secondary study objectives
Fat-soluble vitamin concentration in blood
Fat-soluble vitamins
Leeds Dyspepsia Questionnaire
+2 more
Other study objectives
Absolute Basophils
Absolute Blasts
Absolute Eosinophils
+49 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ZypanExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

National University of Natural MedicineLead Sponsor
31 Previous Clinical Trials
1,215 Total Patients Enrolled
~3 spots leftby Dec 2024